DRUG RECALL

Estrogen Recalled

October 6, 2016

The US Food and Drug Administration (FDA) reported the recall of conjugated estrogen tablets (Premarin), USP, 1.25 mg (NDC 0046-1104-91).

More than 1,300 bottles—totaling more than 1.3 million tablets—are included in in the recall.

What prompted the Class III recall? The bottles contained the incorrect expiration date. The impacted lot is #M35953S, with an incorrect expiration date of November 2017. The correct expiration is September 2017.
__________________________________________________________________________________________________________________________________________________________________________
RELATED CONTENT
Massive Recall of Blood Thinners, Antibiotic
Sandoz Recalls Hypotension Med, Vasoconstrictor
__________________________________________________________________________________________________________________________________________________________________________

The products were distributed nationwide by Wyeth Pharmaceuticals, a subsidiary of Pfizer.

In June, Pfizer recalled more than 68,000 bottles of an SSRI after the tablets were found to be too thick. In April, the company recalled more than 63,000 bottles of a cough medicine.

 

--Stephanie Vaccaro

 

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of October 5, 2016. www.fda.gov. Accessed October 5, 2016.